Wikisage, the free encyclopedia of the second generation, is digital heritage
Riluzole: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
Riluzole Rhone Poulenc is a medicament marketed as natrium channel blocking agent with a modest benefit on [[Amyotrophic_lateral_sclerosis| ALS]]. | Riluzole Rhone Poulenc is a medicament marketed as natrium channel blocking agent with a modest benefit on [[Amyotrophic_lateral_sclerosis| ALS]]. | ||
<gallery>File:Riluzole.svg.png</gallery> | <gallery>File:Riluzole.svg.png|6-(Trifluormethoxy)-1,3-benzothiazol-2-amine</gallery> | ||
{{Wikidata|Q415744}} | {{Wikidata|Q415744}} | ||
[[Category:anticonvulsants]] | [[Category:anticonvulsants]] | ||
Revision as of 23:17, 29 January 2023
Riluzole Rhone Poulenc is a medicament marketed as natrium channel blocking agent with a modest benefit on ALS.
-
6-(Trifluormethoxy)-1,3-benzothiazol-2-amine
